NCT02936323 2021-12-14PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung CancersTarveda TherapeuticsPhase 1/2 Completed89 enrolled 30 charts